Document is current
Any future updates will be listed below
-
Authors
Abuhelwa, Ahmad Y.
Almansour, Sara A
Al-Shamsi, Humaid O.
Abuhelwa, Ziad
Alqudah, Mohammad A. Y.
Bustanji, Yasser
Semreen, Mohammad H
Alzoubi, Karem H
Modi, Natansh D
McKinnon, Ross A
Sorich, Michael J.
Hopkins, Ashley M
-
Funding
Funding for this research was provided by:
University of Sharjah Targeted Grant (2301110392)
Tour De Cure Research Grant (RSP-117-FY2023)
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 22 January 2026
First Online: 7 February 2026
Declarations
:
: HOA is on the advisory board of ROCHE, MSD, BMS, ASTRAZENECA, and Novartis. All other authors have no conflict of interest to disclose.
: The secondary analysis of de-identified data reported in this study was considered negligible risk research and has been approved by the University of Sharjah Ethics Committee (Approval reference number: REC-23-11-07-01-F).
: Not applicable to this independent, secondary analysis study.
